Global Metabotropic Glutamate Receptor 3 Market Research Report 2024

Report ID: 1978135 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 LY-3020371
        1.2.3 VU-0092273
        1.2.4 DT-010991
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Metabotropic Glutamate Receptor 3 Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Autism
        1.3.3 Chronic Pain
        1.3.4 Glioma
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Metabotropic Glutamate Receptor 3 Market Perspective (2017-2028)
    2.2 Metabotropic Glutamate Receptor 3 Growth Trends by Region
        2.2.1 Metabotropic Glutamate Receptor 3 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Metabotropic Glutamate Receptor 3 Historic Market Size by Region (2017-2022)
        2.2.3 Metabotropic Glutamate Receptor 3 Forecasted Market Size by Region (2023-2028)
    2.3 Metabotropic Glutamate Receptor 3 Market Dynamics
        2.3.1 Metabotropic Glutamate Receptor 3 Industry Trends
        2.3.2 Metabotropic Glutamate Receptor 3 Market Drivers
        2.3.3 Metabotropic Glutamate Receptor 3 Market Challenges
        2.3.4 Metabotropic Glutamate Receptor 3 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Metabotropic Glutamate Receptor 3 Players by Revenue
        3.1.1 Global Top Metabotropic Glutamate Receptor 3 Players by Revenue (2017-2022)
        3.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Players (2017-2022)
    3.2 Global Metabotropic Glutamate Receptor 3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabotropic Glutamate Receptor 3 Revenue
    3.4 Global Metabotropic Glutamate Receptor 3 Market Concentration Ratio
        3.4.1 Global Metabotropic Glutamate Receptor 3 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 3 Revenue in 2021
    3.5 Metabotropic Glutamate Receptor 3 Key Players Head office and Area Served
    3.6 Key Players Metabotropic Glutamate Receptor 3 Product Solution and Service
    3.7 Date of Enter into Metabotropic Glutamate Receptor 3 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Metabotropic Glutamate Receptor 3 Breakdown Data by Type
    4.1 Global Metabotropic Glutamate Receptor 3 Historic Market Size by Type (2017-2022)
    4.2 Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Type (2023-2028)
5 Metabotropic Glutamate Receptor 3 Breakdown Data by Application
    5.1 Global Metabotropic Glutamate Receptor 3 Historic Market Size by Application (2017-2022)
    5.2 Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Metabotropic Glutamate Receptor 3 Market Size (2017-2028)
    6.2 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
    6.3 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Metabotropic Glutamate Receptor 3 Market Size (2017-2028)
    7.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
    7.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size (2017-2028)
    8.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
    8.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Metabotropic Glutamate Receptor 3 Market Size (2017-2028)
    9.2 Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
    9.3 Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size (2017-2028)
    10.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
    10.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Addex Therapeutics Ltd
        11.1.1 Addex Therapeutics Ltd Company Detail
        11.1.2 Addex Therapeutics Ltd Business Overview
        11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Introduction
        11.1.4 Addex Therapeutics Ltd Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.1.5 Addex Therapeutics Ltd Recent Development
    11.2 Aevi Genomic Medicine Inc
        11.2.1 Aevi Genomic Medicine Inc Company Detail
        11.2.2 Aevi Genomic Medicine Inc Business Overview
        11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Introduction
        11.2.4 Aevi Genomic Medicine Inc Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.2.5 Aevi Genomic Medicine Inc Recent Development
    11.3 Denovo Biopharma LLC
        11.3.1 Denovo Biopharma LLC Company Detail
        11.3.2 Denovo Biopharma LLC Business Overview
        11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Introduction
        11.3.4 Denovo Biopharma LLC Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.3.5 Denovo Biopharma LLC Recent Development
    11.4 Domain Therapeutics SA
        11.4.1 Domain Therapeutics SA Company Detail
        11.4.2 Domain Therapeutics SA Business Overview
        11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Introduction
        11.4.4 Domain Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.4.5 Domain Therapeutics SA Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Detail
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Introduction
        11.5.4 Eli Lilly and Company Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 Prexton Therapeutics SA
        11.6.1 Prexton Therapeutics SA Company Detail
        11.6.2 Prexton Therapeutics SA Business Overview
        11.6.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Introduction
        11.6.4 Prexton Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022)
        11.6.5 Prexton Therapeutics SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of LY-3020371
    Table 3. Key Players of VU-0092273
    Table 4. Key Players of DT-010991
    Table 5. Key Players of Others
    Table 6. Global Metabotropic Glutamate Receptor 3 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Metabotropic Glutamate Receptor 3 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2017-2022)
    Table 10. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2023-2028)
    Table 12. Metabotropic Glutamate Receptor 3 Market Trends
    Table 13. Metabotropic Glutamate Receptor 3 Market Drivers
    Table 14. Metabotropic Glutamate Receptor 3 Market Challenges
    Table 15. Metabotropic Glutamate Receptor 3 Market Restraints
    Table 16. Global Metabotropic Glutamate Receptor 3 Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Metabotropic Glutamate Receptor 3 Market Share by Players (2017-2022)
    Table 18. Global Top Metabotropic Glutamate Receptor 3 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 3 as of 2021)
    Table 19. Ranking of Global Top Metabotropic Glutamate Receptor 3 Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Metabotropic Glutamate Receptor 3 Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Metabotropic Glutamate Receptor 3 Product Solution and Service
    Table 23. Date of Enter into Metabotropic Glutamate Receptor 3 Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2017-2022)
    Table 27. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2023-2028)
    Table 29. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2017-2022)
    Table 31. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2023-2028)
    Table 33. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Addex Therapeutics Ltd Company Detail
    Table 44. Addex Therapeutics Ltd Business Overview
    Table 45. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product
    Table 46. Addex Therapeutics Ltd Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 47. Addex Therapeutics Ltd Recent Development
    Table 48. Aevi Genomic Medicine Inc Company Detail
    Table 49. Aevi Genomic Medicine Inc Business Overview
    Table 50. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product
    Table 51. Aevi Genomic Medicine Inc Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 52. Aevi Genomic Medicine Inc Recent Development
    Table 53. Denovo Biopharma LLC Company Detail
    Table 54. Denovo Biopharma LLC Business Overview
    Table 55. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product
    Table 56. Denovo Biopharma LLC Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 57. Denovo Biopharma LLC Recent Development
    Table 58. Domain Therapeutics SA Company Detail
    Table 59. Domain Therapeutics SA Business Overview
    Table 60. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product
    Table 61. Domain Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 62. Domain Therapeutics SA Recent Development
    Table 63. Eli Lilly and Company Company Detail
    Table 64. Eli Lilly and Company Business Overview
    Table 65. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product
    Table 66. Eli Lilly and Company Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 67. Eli Lilly and Company Recent Development
    Table 68. Prexton Therapeutics SA Company Detail
    Table 69. Prexton Therapeutics SA Business Overview
    Table 70. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product
    Table 71. Prexton Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2017-2022) & (US$ Million)
    Table 72. Prexton Therapeutics SA Recent Development
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabotropic Glutamate Receptor 3 Market Share by Type: 2021 VS 2028
    Figure 2. LY-3020371 Features
    Figure 3. VU-0092273 Features
    Figure 4. DT-010991 Features
    Figure 5. Others Features
    Figure 6. Global Metabotropic Glutamate Receptor 3 Market Share by Application in 2021 & 2028
    Figure 7. Autism Case Studies
    Figure 8. Chronic Pain Case Studies
    Figure 9. Glioma Case Studies
    Figure 10. Others Case Studies
    Figure 11. Metabotropic Glutamate Receptor 3 Report Years Considered
    Figure 12. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Metabotropic Glutamate Receptor 3 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Metabotropic Glutamate Receptor 3 Market Share by Region: 2021 VS 2028
    Figure 15. Global Metabotropic Glutamate Receptor 3 Market Share by Players in 2021
    Figure 16. Global Top Metabotropic Glutamate Receptor 3 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 3 as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 3 Revenue in 2021
    Figure 18. North America Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Metabotropic Glutamate Receptor 3 Market Share by Country (2017-2028)
    Figure 20. United States Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2017-2028)
    Figure 24. Germany Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Region (2017-2028)
    Figure 32. China Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Metabotropic Glutamate Receptor 3 Market Share by Country (2017-2028)
    Figure 40. Mexico Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2017-2028)
    Figure 44. Turkey Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Addex Therapeutics Ltd Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 47. Aevi Genomic Medicine Inc Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 48. Denovo Biopharma LLC Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 49. Domain Therapeutics SA Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 50. Eli Lilly and Company Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 51. Prexton Therapeutics SA Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Prexton Therapeutics SA
Frequently Asked Questions
Metabotropic Glutamate Receptor 3 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabotropic Glutamate Receptor 3 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabotropic Glutamate Receptor 3 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dress Fabrics

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More